Elbit Imaging Ltd
OTC:EMITF
Gross Margin
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Peer Comparison
| Country | Company | Market Cap |
Gross Margin |
||
|---|---|---|---|---|---|
| IL |
|
Elbit Imaging Ltd
OTC:EMITF
|
21.3m USD |
Loading...
|
|
| US |
|
Abbott Laboratories
NYSE:ABT
|
192B USD |
Loading...
|
|
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
174.6B USD |
Loading...
|
|
| US |
|
Stryker Corp
NYSE:SYK
|
136.5B USD |
Loading...
|
|
| IE |
|
Medtronic PLC
NYSE:MDT
|
131.8B USD |
Loading...
|
|
| US |
|
Boston Scientific Corp
NYSE:BSX
|
112.1B USD |
Loading...
|
|
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
59.8B USD |
Loading...
|
|
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
46.4B EUR |
Loading...
|
|
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
51.6B USD |
Loading...
|
|
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
45.4B USD |
Loading...
|
|
| US |
|
Resmed Inc
NYSE:RMD
|
39.5B USD |
Loading...
|
Market Distribution
| Min | -11 239.1% |
| 30th Percentile | 17.6% |
| Median | 29.8% |
| 70th Percentile | 50.4% |
| Max | 208.2% |
Other Profitability Ratios
Elbit Imaging Ltd
Glance View
Elbit Imaging Ltd. operates as an investment holding company, with interests in the real estate sector in India and in the medical instruments sector in Israel. The firm's segments include Commercial centers, Hotel, Medical Industries and devices, and Plots in India. Commercial centers segment include initiation, construction and sale of commercial centers and other mixed-use real property projects, principally in the retail sector. Hotel segment is engaged in the operation and management of hotels. Medical Industries and devices segment includes research and development, production and marketing of magnetic resonance imaging guided focused ultrasound treatment equipment, and development of stem cell population expansion technologies and stem cell therapy products for transplantation and regenerative medicine. Plots in India segment includes plots designated for sale, initially designated to residential projects.
See Also
Gross Margin is calculated by dividing the Gross Profit by the Revenue.
The current Gross Margin for Elbit Imaging Ltd is 32.2%, which is in line with its 3-year median of 32.2%.
Over the last 0 months, Elbit Imaging Ltd’s Gross Margin has decreased from 32.2% to 32.2%. During this period, it reached a low of 32.2% on Oct 30, 2025 and a high of 32.2% on Oct 30, 2025.
